Sep. 21, 2014, 4:17 AM
- Just months before its recent C-suite shuffle, Clorox (NYSE:CLX) reportedly rebuffed a takeover offer from a rival.
- The spurned suitor valued Clorox at a 20% premium to its trading price.
- Logical suitors include Church & Dwight (NYSE:CHD), Procter & Gamble (NYSE:PG), Jarden (NYSE:JAH) and Unilever (UL, UN)
- In 2011 activist investor Carl Icahn offered $78/share for the company. Many believe the move was designed to tease out a strategic buyer. Shares closed Friday at $90.57.
Apr. 30, 2013, 3:50 AMUnilever (UN, UL) offers as much as $5.4B to boost its stake in its Indian unit Hindustan Unilever to a maximum of 75%. Unilever's 600 rupee/share bid is a 20.6% premium to Monday's close, but analysts say that may not be enough to entice foreign funds holding the shares to gain exposure to a hot Indian market. (PR) | 1 Comment
Oct. 14, 2011, 9:09 AM
Jul. 15, 2011, 6:25 AMIcahn notes Clorox (CLX) "will not come close" to meeting sales growth forecasts of 3-5%/year. His offer is an attempt to prod CLX to pursue a deal with a "strategic buyer" (PG, UN, CL, KMB, Reckitt Benckiser, Henkel) - who Icahn believes will pay a higher price. "Quite simply, there are few strategic opportunities like Clorox." | 1 Comment
May. 6, 2011, 2:42 PM
UN vs. ETF Alternatives
Other News & PR